Respiratory syncytial virus (RSV) antibody and small-molecule drugs: current status of clinical translation and challenges
Backgroundrespiratory syncytial virus (RSV) remains a leading cause of lower respiratory tract infections worldwide, imposing a substantial disease burden on infants, older adults, and immunocompromised individuals. Despite its prevalence, therapeutic options have historically been limited, with no...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Frontiers Media S.A.
2026-02-01
|
| Schriftenreihe: | Frontiers in Microbiology |
| Schlagworte: | |
| Online-Zugang: | https://www.frontiersin.org/articles/10.3389/fmicb.2026.1745808/full |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|